サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1123413

世界の増殖糖尿病網膜症市場：考察と予測 (2028年まで)

Global Proliferative Diabetic Retinopathy Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 117 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の増殖糖尿病網膜症市場：考察と予測 (2028年まで)
出版日: 2022年09月08日
発行: QYResearch
ページ情報: 英文 117 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、増殖糖尿病網膜症 (Proliferative Diabetic Retinopathy) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の増殖糖尿病網膜症の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Anti-VEGF Agents
    • Corticosteroids
  • 市場：アプリケーション別
    • 世界の増殖糖尿病網膜症の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospitals
    • Clinics
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の増殖糖尿病網膜症の市場展望 (2017-2028)
  • 増殖糖尿病網膜症の市場成長トレンド：地域別
    • 増殖糖尿病網膜症 市場規模：地域別: 2017 VS 2021 VS 2028
    • 増殖糖尿病網膜症の市場規模実績：地域別 (2017-2022)
    • 増殖糖尿病網膜症の市場規模予測：地域別 (2023-2028)
  • 増殖糖尿病網膜症 市場動向
    • 増殖糖尿病網膜症 業界動向
    • 増殖糖尿病網膜症 市場の促進要因
    • 増殖糖尿病網膜症 市場の課題
    • 増殖糖尿病網膜症 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の増殖糖尿病網膜症の上位企業：収益別
    • 世界の増殖糖尿病網膜症の上位企業：収益別 (2017-2022)
    • 世界の増殖糖尿病網膜症の収益シェア：企業別 (2017-2022)
  • 世界の増殖糖尿病網膜症の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：増殖糖尿病網膜症の収益
  • 世界の増殖糖尿病網膜症 市場集中度
    • 世界の増殖糖尿病網膜症 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 増殖糖尿病網膜症の収益 2021
  • 増殖糖尿病網膜症の主要企業の本社および事業エリア
  • 主要企業 増殖糖尿病網膜症の製品ソリューションおよびサービス
  • 市場参入時期： 増殖糖尿病網膜症 市場
  • M&A, 拡張計画

第4章 増殖糖尿病網膜症 内訳データ：タイプ別

  • 世界の増殖糖尿病網膜症の市場規模実績：タイプ別 (2017-2022)
  • 世界の増殖糖尿病網膜症の市場規模予測：タイプ別 (2023-2028)

第5章 増殖糖尿病網膜症 内訳データ：アプリケーション別

  • 世界の増殖糖尿病網膜症の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の増殖糖尿病網膜症の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の増殖糖尿病網膜症 市場規模 (2017-2028)
  • 北米の増殖糖尿病網膜症 市場規模：タイプ別
    • 北米の増殖糖尿病網膜症 市場規模：タイプ別 (2017-2022)
    • 北米の増殖糖尿病網膜症 市場規模：タイプ別 (2023-2028)
    • 北米の増殖糖尿病網膜症の市場シェア：タイプ別 (2017-2028)
  • 北米の増殖糖尿病網膜症 市場規模：アプリケーション別
    • 北米の増殖糖尿病網膜症 市場規模：アプリケーション別 (2017-2022)
    • 北米の増殖糖尿病網膜症 市場規模：アプリケーション別 (2023-2028)
    • 北米の増殖糖尿病網膜症の市場シェア：アプリケーション別 (2017-2028)
  • 北米の増殖糖尿病網膜症 市場規模：国別
    • 北米の増殖糖尿病網膜症 市場規模：国別 (2017-2022)
    • 北米の増殖糖尿病網膜症 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の増殖糖尿病網膜症 市場規模 (2017-2028)
  • 欧州の増殖糖尿病網膜症 市場規模：タイプ別
    • 欧州の増殖糖尿病網膜症 市場規模：タイプ別 (2017-2022)
    • 欧州の増殖糖尿病網膜症 市場規模：タイプ別 (2023-2028)
    • 欧州の増殖糖尿病網膜症の市場シェア：タイプ別 (2017-2028)
  • 欧州の増殖糖尿病網膜症 市場規模：アプリケーション別
    • 欧州の増殖糖尿病網膜症 市場規模：アプリケーション別 (2017-2022)
    • 欧州の増殖糖尿病網膜症 市場規模：アプリケーション別 (2023-2028)
    • 欧州の増殖糖尿病網膜症の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の増殖糖尿病網膜症 市場規模：国別
    • 欧州の増殖糖尿病網膜症 市場規模：国別 (2017-2022)
    • 欧州の増殖糖尿病網膜症 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 増殖糖尿病網膜症 市場規模 (2017-2028)
  • アジア太平洋地域 増殖糖尿病網膜症 市場規模：タイプ別
    • アジア太平洋地域 増殖糖尿病網膜症 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 増殖糖尿病網膜症 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 増殖糖尿病網膜症の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 増殖糖尿病網膜症 市場規模：アプリケーション別
    • アジア太平洋地域 増殖糖尿病網膜症 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 増殖糖尿病網膜症 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 増殖糖尿病網膜症の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 増殖糖尿病網膜症 市場規模：地域別
    • アジア太平洋地域 増殖糖尿病網膜症 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 増殖糖尿病網膜症 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの増殖糖尿病網膜症 市場規模 (2017-2028)
  • ラテンアメリカの増殖糖尿病網膜症 市場規模：タイプ別
    • ラテンアメリカの増殖糖尿病網膜症 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの増殖糖尿病網膜症 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの増殖糖尿病網膜症の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの増殖糖尿病網膜症 市場規模：アプリケーション別
    • ラテンアメリカの増殖糖尿病網膜症 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの増殖糖尿病網膜症 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの増殖糖尿病網膜症の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの増殖糖尿病網膜症 市場規模：国別
    • ラテンアメリカの増殖糖尿病網膜症 市場規模：国別 (2017-2022)
    • ラテンアメリカの増殖糖尿病網膜症 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの増殖糖尿病網膜症 市場規模 (2017-2028)
  • 中東・アフリカの増殖糖尿病網膜症 市場規模：タイプ別
    • 中東・アフリカの増殖糖尿病網膜症 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの増殖糖尿病網膜症 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの増殖糖尿病網膜症の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの増殖糖尿病網膜症 市場規模：アプリケーション別
    • 中東・アフリカの増殖糖尿病網膜症 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの増殖糖尿病網膜症 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの増殖糖尿病網膜症の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの増殖糖尿病網膜症 市場規模：国別
    • 中東・アフリカの増殖糖尿病網膜症 市場規模：国別 (2017-2022)
    • 中東・アフリカの増殖糖尿病網膜症 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Intas Pharmaceuticals
  • Santen Pharmaceutical
  • Bausch Health
  • Allergan Plc
  • Regeneron Pharmaceuticals
  • Merck KGaA
  • Cipla
  • Genentech, Inc. (Roche Holdings)
  • Novartis
  • Pfizer

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Anti-VEGF Agents
  • Table 3. Key Players of Corticosteroids
  • Table 4. Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Proliferative Diabetic Retinopathy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Proliferative Diabetic Retinopathy Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Proliferative Diabetic Retinopathy Market Share by Region (2017-2022)
  • Table 8. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Proliferative Diabetic Retinopathy Market Share by Region (2023-2028)
  • Table 10. Proliferative Diabetic Retinopathy Market Trends
  • Table 11. Proliferative Diabetic Retinopathy Market Drivers
  • Table 12. Proliferative Diabetic Retinopathy Market Challenges
  • Table 13. Proliferative Diabetic Retinopathy Market Restraints
  • Table 14. Global Proliferative Diabetic Retinopathy Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Proliferative Diabetic Retinopathy Revenue Share by Players (2017-2022)
  • Table 16. Global Top Proliferative Diabetic Retinopathy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy as of 2021)
  • Table 17. Ranking of Global Top Proliferative Diabetic Retinopathy Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Proliferative Diabetic Retinopathy Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Proliferative Diabetic Retinopathy Product Solution and Service
  • Table 21. Date of Enter into Proliferative Diabetic Retinopathy Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Proliferative Diabetic Retinopathy Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2017-2022)
  • Table 25. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2023-2028)
  • Table 27. Global Proliferative Diabetic Retinopathy Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Proliferative Diabetic Retinopathy Revenue Share by Application (2017-2022)
  • Table 29. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Proliferative Diabetic Retinopathy Revenue Share by Application (2023-2028)
  • Table 31. North America Proliferative Diabetic Retinopathy Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Proliferative Diabetic Retinopathy Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Proliferative Diabetic Retinopathy Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Proliferative Diabetic Retinopathy Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Proliferative Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Proliferative Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Proliferative Diabetic Retinopathy Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Proliferative Diabetic Retinopathy Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Proliferative Diabetic Retinopathy Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Proliferative Diabetic Retinopathy Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Proliferative Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Proliferative Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Proliferative Diabetic Retinopathy Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Proliferative Diabetic Retinopathy Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Proliferative Diabetic Retinopathy Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Proliferative Diabetic Retinopathy Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Proliferative Diabetic Retinopathy Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Proliferative Diabetic Retinopathy Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Proliferative Diabetic Retinopathy Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Proliferative Diabetic Retinopathy Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Proliferative Diabetic Retinopathy Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Proliferative Diabetic Retinopathy Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Proliferative Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Proliferative Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Proliferative Diabetic Retinopathy Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Proliferative Diabetic Retinopathy Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Proliferative Diabetic Retinopathy Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Proliferative Diabetic Retinopathy Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Proliferative Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Proliferative Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Intas Pharmaceuticals Company Details
  • Table 62. Intas Pharmaceuticals Business Overview
  • Table 63. Intas Pharmaceuticals Proliferative Diabetic Retinopathy Product
  • Table 64. Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 65. Intas Pharmaceuticals Recent Developments
  • Table 66. Santen Pharmaceutical Company Details
  • Table 67. Santen Pharmaceutical Business Overview
  • Table 68. Santen Pharmaceutical Proliferative Diabetic Retinopathy Product
  • Table 69. Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 70. Santen Pharmaceutical Recent Developments
  • Table 71. Bausch Health Company Details
  • Table 72. Bausch Health Business Overview
  • Table 73. Bausch Health Proliferative Diabetic Retinopathy Product
  • Table 74. Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 75. Bausch Health Recent Developments
  • Table 76. Allergan Plc Company Details
  • Table 77. Allergan Plc Business Overview
  • Table 78. Allergan Plc Proliferative Diabetic Retinopathy Product
  • Table 79. Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 80. Allergan Plc Recent Developments
  • Table 81. Regeneron Pharmaceuticals Company Details
  • Table 82. Regeneron Pharmaceuticals Business Overview
  • Table 83. Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Product
  • Table 84. Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 85. Regeneron Pharmaceuticals Recent Developments
  • Table 86. Merck KGaA Company Details
  • Table 87. Merck KGaA Business Overview
  • Table 88. Merck KGaA Proliferative Diabetic Retinopathy Product
  • Table 89. Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 90. Merck KGaA Recent Developments
  • Table 91. Cipla Company Details
  • Table 92. Cipla Business Overview
  • Table 93. Cipla Proliferative Diabetic Retinopathy Product
  • Table 94. Cipla Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 95. Cipla Recent Developments
  • Table 96. Genentech, Inc. (Roche Holdings) Company Details
  • Table 97. Genentech, Inc. (Roche Holdings) Business Overview
  • Table 98. Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Product
  • Table 99. Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 100. Genentech, Inc. (Roche Holdings) Recent Developments
  • Table 101. Novartis Company Details
  • Table 102. Novartis Business Overview
  • Table 103. Novartis Proliferative Diabetic Retinopathy Product
  • Table 104. Novartis Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 105. Novartis Recent Developments
  • Table 106. Pfizer Company Details
  • Table 107. Pfizer Business Overview
  • Table 108. Pfizer Proliferative Diabetic Retinopathy Product
  • Table 109. Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
  • Table 110. Pfizer Recent Developments
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Proliferative Diabetic Retinopathy Market Share by Type: 2021 VS 2028
  • Figure 2. Anti-VEGF Agents Features
  • Figure 3. Corticosteroids Features
  • Figure 4. Global Proliferative Diabetic Retinopathy Market Share by Application: 2021 VS 2028
  • Figure 5. Hospitals Case Studies
  • Figure 6. Clinics Case Studies
  • Figure 7. Others Case Studies
  • Figure 8. Proliferative Diabetic Retinopathy Report Years Considered
  • Figure 9. Global Proliferative Diabetic Retinopathy Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 10. Global Proliferative Diabetic Retinopathy Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Proliferative Diabetic Retinopathy Market Share by Region: 2021 VS 2028
  • Figure 12. Global Proliferative Diabetic Retinopathy Market Share by Players in 2021
  • Figure 13. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy as of 2021)
  • Figure 14. The Top 10 and 5 Players Market Share by Proliferative Diabetic Retinopathy Revenue in 2021
  • Figure 15. North America Proliferative Diabetic Retinopathy Market Size YoY (2017-2028) & (US$ Million)
  • Figure 16. North America Proliferative Diabetic Retinopathy Market Size Market Share by Type (2017-2028)
  • Figure 17. North America Proliferative Diabetic Retinopathy Market Size Market Share by Application (2017-2028)
  • Figure 18. North America Proliferative Diabetic Retinopathy Market Size Share by Country (2017-2028)
  • Figure 19. United States Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Canada Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Europe Proliferative Diabetic Retinopathy Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. Europe Proliferative Diabetic Retinopathy Market Size Market Share by Type (2017-2028)
  • Figure 23. Europe Proliferative Diabetic Retinopathy Market Size Market Share by Application (2017-2028)
  • Figure 24. Europe Proliferative Diabetic Retinopathy Market Size Share by Country (2017-2028)
  • Figure 25. Germany Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. France Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. U.K. Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Italy Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Russia Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Nordic Countries Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Asia-Pacific Proliferative Diabetic Retinopathy Market Size YoY (2017-2028) & (US$ Million)
  • Figure 32. Asia Pacific Proliferative Diabetic Retinopathy Market Size Market Share by Type (2017-2028)
  • Figure 33. Asia Pacific Proliferative Diabetic Retinopathy Market Size Market Share by Application (2017-2028)
  • Figure 34. Asia Pacific Proliferative Diabetic Retinopathy Market Size Share by Region (2017-2028)
  • Figure 35. China Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Japan Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. South Korea Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Southeast Asia Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. India Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Australia Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 41. Latin America Proliferative Diabetic Retinopathy Market Size YoY (2017-2028) & (US$ Million)
  • Figure 42. Latin America Proliferative Diabetic Retinopathy Market Size Market Share by Type (2017-2028)
  • Figure 43. Latin America Proliferative Diabetic Retinopathy Market Size Market Share by Application (2017-2028)
  • Figure 44. Latin America Proliferative Diabetic Retinopathy Market Size Share by Country (2017-2028)
  • Figure 45. Mexico Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Brazil Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Middle East & Africa Proliferative Diabetic Retinopathy Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Middle East and Africa Proliferative Diabetic Retinopathy Market Size Market Share by Type (2017-2028)
  • Figure 49. Middle East and Africa Proliferative Diabetic Retinopathy Market Size Market Share by Application (2017-2028)
  • Figure 50. Middle East and Africa Proliferative Diabetic Retinopathy Market Size Share by Country (2017-2028)
  • Figure 51. Turkey Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Saudi Arabia Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. UAE Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Intas Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 55. Santen Pharmaceutical Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 56. Bausch Health Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 57. Allergan Plc Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 59. Merck KGaA Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 60. Cipla Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 61. Genentech, Inc. (Roche Holdings) Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 62. Novartis Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 63. Pfizer Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed
目次

This research report focuses on the Proliferative Diabetic Retinopathy Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Anti-VEGF Agents
    • 1.2.3 Corticosteroids
  • 1.3 Market by Application
    • 1.3.1 Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Proliferative Diabetic Retinopathy Market Perspective (2017-2028)
  • 2.2 Proliferative Diabetic Retinopathy Growth Trends by Region
    • 2.2.1 Proliferative Diabetic Retinopathy Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Proliferative Diabetic Retinopathy Historic Market Size by Region (2017-2022)
    • 2.2.3 Proliferative Diabetic Retinopathy Forecasted Market Size by Region (2023-2028)
  • 2.3 Proliferative Diabetic Retinopathy Market Dynamics
    • 2.3.1 Proliferative Diabetic Retinopathy Industry Trends
    • 2.3.2 Proliferative Diabetic Retinopathy Market Drivers
    • 2.3.3 Proliferative Diabetic Retinopathy Market Challenges
    • 2.3.4 Proliferative Diabetic Retinopathy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue
    • 3.1.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue (2017-2022)
    • 3.1.2 Global Proliferative Diabetic Retinopathy Revenue Market Share by Players (2017-2022)
  • 3.2 Global Proliferative Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Proliferative Diabetic Retinopathy Revenue
  • 3.4 Global Proliferative Diabetic Retinopathy Market Concentration Ratio
    • 3.4.1 Global Proliferative Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Proliferative Diabetic Retinopathy Revenue in 2021
  • 3.5 Proliferative Diabetic Retinopathy Key Players Head office and Area Served
  • 3.6 Key Players Proliferative Diabetic Retinopathy Product Solution and Service
  • 3.7 Date of Enter into Proliferative Diabetic Retinopathy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Proliferative Diabetic Retinopathy Breakdown Data by Type

  • 4.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Type (2017-2022)
  • 4.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2023-2028)

5 Proliferative Diabetic Retinopathy Breakdown Data by Application

  • 5.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Application (2017-2022)
  • 5.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Proliferative Diabetic Retinopathy Market Size (2017-2028)
  • 6.2 North America Proliferative Diabetic Retinopathy Market Size by Type
    • 6.2.1 North America Proliferative Diabetic Retinopathy Market Size by Type (2017-2022)
    • 6.2.2 North America Proliferative Diabetic Retinopathy Market Size by Type (2023-2028)
    • 6.2.3 North America Proliferative Diabetic Retinopathy Market Share by Type (2017-2028)
  • 6.3 North America Proliferative Diabetic Retinopathy Market Size by Application
    • 6.3.1 North America Proliferative Diabetic Retinopathy Market Size by Application (2017-2022)
    • 6.3.2 North America Proliferative Diabetic Retinopathy Market Size by Application (2023-2028)
    • 6.3.3 North America Proliferative Diabetic Retinopathy Market Share by Application (2017-2028)
  • 6.4 North America Proliferative Diabetic Retinopathy Market Size by Country
    • 6.4.1 North America Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
    • 6.4.2 North America Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Proliferative Diabetic Retinopathy Market Size (2017-2028)
  • 7.2 Europe Proliferative Diabetic Retinopathy Market Size by Type
    • 7.2.1 Europe Proliferative Diabetic Retinopathy Market Size by Type (2017-2022)
    • 7.2.2 Europe Proliferative Diabetic Retinopathy Market Size by Type (2023-2028)
    • 7.2.3 Europe Proliferative Diabetic Retinopathy Market Share by Type (2017-2028)
  • 7.3 Europe Proliferative Diabetic Retinopathy Market Size by Application
    • 7.3.1 Europe Proliferative Diabetic Retinopathy Market Size by Application (2017-2022)
    • 7.3.2 Europe Proliferative Diabetic Retinopathy Market Size by Application (2023-2028)
    • 7.3.3 Europe Proliferative Diabetic Retinopathy Market Share by Application (2017-2028)
  • 7.4 Europe Proliferative Diabetic Retinopathy Market Size by Country
    • 7.4.1 Europe Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
    • 7.4.2 Europe Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size (2017-2028)
  • 8.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type
    • 8.2.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application
    • 8.3.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region
    • 8.4.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Proliferative Diabetic Retinopathy Market Size (2017-2028)
  • 9.2 Latin America Proliferative Diabetic Retinopathy Market Size by Type
    • 9.2.1 Latin America Proliferative Diabetic Retinopathy Market Size by Type (2017-2022)
    • 9.2.2 Latin America Proliferative Diabetic Retinopathy Market Size by Type (2023-2028)
    • 9.2.3 Latin America Proliferative Diabetic Retinopathy Market Share by Type (2017-2028)
  • 9.3 Latin America Proliferative Diabetic Retinopathy Market Size by Application
    • 9.3.1 Latin America Proliferative Diabetic Retinopathy Market Size by Application (2017-2022)
    • 9.3.2 Latin America Proliferative Diabetic Retinopathy Market Size by Application (2023-2028)
    • 9.3.3 Latin America Proliferative Diabetic Retinopathy Market Share by Application (2017-2028)
  • 9.4 Latin America Proliferative Diabetic Retinopathy Market Size by Country
    • 9.4.1 Latin America Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
    • 9.4.2 Latin America Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size (2017-2028)
  • 10.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type
    • 10.2.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application
    • 10.3.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country
    • 10.4.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Intas Pharmaceuticals
    • 11.1.1 Intas Pharmaceuticals Company Details
    • 11.1.2 Intas Pharmaceuticals Business Overview
    • 11.1.3 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
    • 11.1.4 Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.1.5 Intas Pharmaceuticals Recent Developments
  • 11.2 Santen Pharmaceutical
    • 11.2.1 Santen Pharmaceutical Company Details
    • 11.2.2 Santen Pharmaceutical Business Overview
    • 11.2.3 Santen Pharmaceutical Proliferative Diabetic Retinopathy Introduction
    • 11.2.4 Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.2.5 Santen Pharmaceutical Recent Developments
  • 11.3 Bausch Health
    • 11.3.1 Bausch Health Company Details
    • 11.3.2 Bausch Health Business Overview
    • 11.3.3 Bausch Health Proliferative Diabetic Retinopathy Introduction
    • 11.3.4 Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.3.5 Bausch Health Recent Developments
  • 11.4 Allergan Plc
    • 11.4.1 Allergan Plc Company Details
    • 11.4.2 Allergan Plc Business Overview
    • 11.4.3 Allergan Plc Proliferative Diabetic Retinopathy Introduction
    • 11.4.4 Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.4.5 Allergan Plc Recent Developments
  • 11.5 Regeneron Pharmaceuticals
    • 11.5.1 Regeneron Pharmaceuticals Company Details
    • 11.5.2 Regeneron Pharmaceuticals Business Overview
    • 11.5.3 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
    • 11.5.4 Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.5.5 Regeneron Pharmaceuticals Recent Developments
  • 11.6 Merck KGaA
    • 11.6.1 Merck KGaA Company Details
    • 11.6.2 Merck KGaA Business Overview
    • 11.6.3 Merck KGaA Proliferative Diabetic Retinopathy Introduction
    • 11.6.4 Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.6.5 Merck KGaA Recent Developments
  • 11.7 Cipla
    • 11.7.1 Cipla Company Details
    • 11.7.2 Cipla Business Overview
    • 11.7.3 Cipla Proliferative Diabetic Retinopathy Introduction
    • 11.7.4 Cipla Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.7.5 Cipla Recent Developments
  • 11.8 Genentech, Inc. (Roche Holdings)
    • 11.8.1 Genentech, Inc. (Roche Holdings) Company Details
    • 11.8.2 Genentech, Inc. (Roche Holdings) Business Overview
    • 11.8.3 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Introduction
    • 11.8.4 Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.8.5 Genentech, Inc. (Roche Holdings) Recent Developments
  • 11.9 Novartis
    • 11.9.1 Novartis Company Details
    • 11.9.2 Novartis Business Overview
    • 11.9.3 Novartis Proliferative Diabetic Retinopathy Introduction
    • 11.9.4 Novartis Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.9.5 Novartis Recent Developments
  • 11.10 Pfizer
    • 11.10.1 Pfizer Company Details
    • 11.10.2 Pfizer Business Overview
    • 11.10.3 Pfizer Proliferative Diabetic Retinopathy Introduction
    • 11.10.4 Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
    • 11.10.5 Pfizer Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer